Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia-Reference-Cited by-同舟云学术

Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia

Published:2005-07-14 Issue:9 Volume:19 Page:1689-1692
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Roy L,Guilhot J,Martineau G,Larchée R,Guilhot F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403874.pdf

Reference13 articles.

1. Deininger M, Buchdunger E, Druker BJ . The development of imatinib as a therapeutic agent for chronic myeloid leukaemia. Blood 2005; 105: 2640–2653.

2. O’Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F et al. Interferon and low-dose cytarabine compared with Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348: 994–1004.

3. Guilhot F . Sustained durability of responses plus high rates of cytogenetic responses result in long-term benefit for newly diagnosed chronic-phase chronic myeloid leukaemia (CML-CP) treated with Imatinib (IM) therapy: update from the IRIS study. Blood 2004; 104 (Suppl 1): 10a.

4. Cortes J, O’Brien S, Kantarjian H . Discontinuation of imatinib therapy after achieving a molecular response. Blood 2004; 104: 2204–2205.

5. Guilhot F . Indications for imatinib mesylate therapy and clinical management. Oncologist 2004; 9: 271–281.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of primary cutaneous diffuse large B-cell lymphoma in chronic myeloid leukemia after treatment with dasatinib;JAAD Case Reports;2024-08

2. A Rare Case of Metastatic Small Cell Carcinoma of Lung in a Follow-Up Patient of Chronic Myeloid Leukemia on Imatinib Treatment;Cureus;2023-02-24

3. Comparison of the efficacy of second and third generation lentiviral vector transduced CAR CD19 T cells for use in the treatment of acute lymphoblastic leukemia both in vitro and in vivo models;PLOS ONE;2023-02-13

4. Follicular Lymphoma Secondary to Chronic Myeloid Leukemia During Treatment With Imatinib;Cureus;2022-11-25

5. Long‐term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls;eJHaem;2022-06-07